Although the U.S. Supreme Court has recently shied away from patent cases, Partner Laura Smalley of our Intellectual Property Law group has explained in several media outlets why that silence speaks volumes—and presents significant challenges for patent practitioners and lower courts alike. She also teamed up with Partner Brian Ginsberg of our Appellate Practice group to discuss the future of the Supreme Court’s patent docket. You can read insights here:

• Chemical Reactions as Law of Nature: Will American Axle Apply to Chemical and Biotech Process Claims? New Jersey Law Journal, Oct. 13
• Life Sciences Patents After American Axle — Grave Danger or Temporary Uncertainty? IP Watchdog, Oct. 4
• The Denial of Certiorari in ‘American Axle’: What It Means for Patent Law and What (If Anything) It Says About the Supreme Court’s Case-Selection Criteria, NY Law Journal, Aug. 16